Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miriam Koopman

Showing results (101-110 of 193) with videos related to

Pageof 20
Sort By:
European Journal of Cancer (Oxford, England : 1990)|February 22, 2026
Safety and feasibility of S-1 after capecitabine-induced toxicity in the adjuvant treatment of colon cancer patients: A population-based real-world studyAvin Ghedri, Frederieke H van der Baan, Johannes M M B Otten, et al.
Current Treatment Options in Oncology|February 17, 2024
Harnessing the Potential of Real-World Evidence in the Treatment of Colorectal Cancer: Where Do We Stand?Sietske C M W van Nassau, Guus M Bol, Frederieke H van der Baan, et al.
Trials|April 19, 2015
RandomizEd controlled trial for pre-operAtive dose-escaLation BOOST in locally advanced rectal cancer (RECTAL BOOST study): study protocol for a randomized controlled trialJ P Maarten Burbach, Helena M Verkooijen, Martijn Intven, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 24, 2021
Early Cost-effectiveness Analysis of Risk-Based Selection Strategies for Adjuvant Treatment in Stage II Colon Cancer: The Potential Value of Prognostic Molecular MarkersGabrielle Jongeneel, Marjolein J E Greuter, Natalia Kunst, et al.
Plos One|July 30, 2013
Clinical and laboratory toxicity after intra-arterial radioembolization with (90)y-microspheres for unresectable liver metastasesMaarten L J Smits, Andor F van den Hoven, Charlotte E N M Rosenbaum, et al.
Acta Oncologica (Stockholm, Sweden)|March 7, 2022
External validation of the MSKCC nomogram to estimate five-year overall survival after surgery for stage I-III colon cancer in a Dutch populationMarinde J G Bond, Patricia A H Hamers, Geraldine R Vink, et al.
European Journal of Cancer (Oxford, England : 1990)|July 20, 2012
Practical feasibility of outcomes research in oncology: lessons learned in assessing drug use and cost-effectiveness in The NetherlandsMargreet G Franken, Chantal W M van Gils, Jennifer G Gaultney, et al.
Clinical Nutrition (Edinburgh, Scotland)|August 2, 2024
Dietary and lifestyle inflammation scores in relation to colorectal cancer recurrence and all-cause mortality: A longitudinal analysisEvertine Wesselink, Hendriek C Boshuizen, Anne-Sophie van Lanen, et al.
JAMA Network Open|September 10, 2021
Trends in Use and Perceptions About Triplet Chemotherapy Plus Bevacizumab for Metastatic Colorectal CancerSietske C van Nassau, Marinde J Bond, Ilva Scheerman, et al.
Annals of Surgical Oncology|August 1, 2023
Survival of Patients with Deficient Mismatch Repair Versus Proficient Mismatch Repair Metastatic Colorectal Cancer Receiving Curative-Intent Local Treatment of Metastases in a Nationwide CohortKoen Zwart, Frederieke H van der Baan, Cornelis J A Punt, et al.
Pageof 20

Showing results (101-110 of 193) with videos related to

Sort By:
Pageof 20
European Journal of Cancer (Oxford, England : 1990)|February 22, 2026
Safety and feasibility of S-1 after capecitabine-induced toxicity in the adjuvant treatment of colon cancer patients: A population-based real-world studyAvin Ghedri, Frederieke H van der Baan, Johannes M M B Otten, et al.
Current Treatment Options in Oncology|February 17, 2024
Harnessing the Potential of Real-World Evidence in the Treatment of Colorectal Cancer: Where Do We Stand?Sietske C M W van Nassau, Guus M Bol, Frederieke H van der Baan, et al.
Trials|April 19, 2015
RandomizEd controlled trial for pre-operAtive dose-escaLation BOOST in locally advanced rectal cancer (RECTAL BOOST study): study protocol for a randomized controlled trialJ P Maarten Burbach, Helena M Verkooijen, Martijn Intven, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 24, 2021
Early Cost-effectiveness Analysis of Risk-Based Selection Strategies for Adjuvant Treatment in Stage II Colon Cancer: The Potential Value of Prognostic Molecular MarkersGabrielle Jongeneel, Marjolein J E Greuter, Natalia Kunst, et al.
Plos One|July 30, 2013
Clinical and laboratory toxicity after intra-arterial radioembolization with (90)y-microspheres for unresectable liver metastasesMaarten L J Smits, Andor F van den Hoven, Charlotte E N M Rosenbaum, et al.
Acta Oncologica (Stockholm, Sweden)|March 7, 2022
External validation of the MSKCC nomogram to estimate five-year overall survival after surgery for stage I-III colon cancer in a Dutch populationMarinde J G Bond, Patricia A H Hamers, Geraldine R Vink, et al.
European Journal of Cancer (Oxford, England : 1990)|July 20, 2012
Practical feasibility of outcomes research in oncology: lessons learned in assessing drug use and cost-effectiveness in The NetherlandsMargreet G Franken, Chantal W M van Gils, Jennifer G Gaultney, et al.
Clinical Nutrition (Edinburgh, Scotland)|August 2, 2024
Dietary and lifestyle inflammation scores in relation to colorectal cancer recurrence and all-cause mortality: A longitudinal analysisEvertine Wesselink, Hendriek C Boshuizen, Anne-Sophie van Lanen, et al.
JAMA Network Open|September 10, 2021
Trends in Use and Perceptions About Triplet Chemotherapy Plus Bevacizumab for Metastatic Colorectal CancerSietske C van Nassau, Marinde J Bond, Ilva Scheerman, et al.
Annals of Surgical Oncology|August 1, 2023
Survival of Patients with Deficient Mismatch Repair Versus Proficient Mismatch Repair Metastatic Colorectal Cancer Receiving Curative-Intent Local Treatment of Metastases in a Nationwide CohortKoen Zwart, Frederieke H van der Baan, Cornelis J A Punt, et al.
Pageof 20